South African tycoon Gus Attridge’s stake in Africa’s biggest pharma company hits $215 million
Attridge’s recent financial triumph is attributed to the recent surge in Aspen Pharmacare’s shares on the Johannesburg Stock Exchange (JSE).
Aspen Pharmacare
South African billionaire Stephen Saad gains $49 million as Aspen shares soar
This increase cements Saad’s position in the South African business scene, placing him among the leading investors on the JSE.
South African tycoon Stephen Saad’s investment in Aspen surpasses $620 million
According to data compiled by Billionaires.Africa, the market value of Saad’s stake in Aspen has increased by $52.4 million to $623.6 million.
South African tycoon Gus Attridge suffers $8-million loss from Aspen shares
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
South African tycoon Gus Attridge gains nearly $8 million in 16 days
Attridge, Aspen’s group chief advisor who ranks as one of JSE’s richest investors, owns a 4.26-percent stake in the pharma group.
South African tycoon Gus Attridge rakes in $19 million from Aspen shares
The upswing comes on the heels of a setback that led to Attridge recording a loss of $11.96 million between Oct. 2 and Oct. 26.
5 companies owned by South African businessman Gus Attridge
At the helm of Aspen Pharmacare, Attridge has made significant contributions to Africa’s healthcare sector.
5 companies owned by South African billionaire Stephen Saad
Beyond Aspen Pharmacare, Saad’s influence extends to a diverse array of companies, each representing a facet of his entrepreneurial prowess.
South African businessman Gus Attridge earns $1.3-million salary from Aspen
Apart from his executive and governance roles in Aspen Pharmacare, Attridge owns a notable 4.28-percent stake in Aspen.
South African businessman Gus Attridge loses $11.96 million in 24 days
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
South African billionaire Stephen Saad earns $2-million salary from Aspen in 2023
Apart from his executive and governance roles in Aspen Pharmacare, Saad also holds a controlling 12.5-percent stake in the company.
South African tycoon Gus Attridge loses $7.2 million in 5 days from Aspen stake
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
Stephen Saad’s Aspen to pioneer South Africa’s first human insulin production
Established in 1997 by Saad, Aspen has steadily expanded its global presence in the pharmaceutical sector.
South African executive Gus Attridge loses $27.3 million in 43 days
Attridge, Aspen’s group chief advisor, owns a 4.26-percent stake in the pharmaceutical company.
South African billionaire Stephen Saad’s Aspen partners with Eli Lilly to expand medical access
Aspen Pharmacare, founded by Saad in 1997, has steadily fortified its global presence in the pharmaceutical sector for over two decades.
South African executive scores big with $55-million gain from Aspen Pharmacare
South African executive Michael Guy Attridge (Gus Attridge) has witnessed a remarkable year-to-date gain of more than $55 million from his stake in Aspen Pharmacare